The Korean guideline for colorectal cancer screening.
10.5124/jkma.2015.58.5.420
- Author:
Dae Kyung SOHN
1
;
Min Ju KIM
;
Younhee PARK
;
Mina SUH
;
Aesun SHIN
;
Hee Young LEE
;
Jong Pil IM
;
Hyoen Min CHO
;
Sung Pil HONG
;
Baek Hui KIM
;
Yongsoo KIM
;
Jeong Wook KIM
;
Hyun Soo KIM
;
Chung Mo NAM
;
Dong Il PARK
;
Jun Won UM
;
Soon Nam OH
;
Hwan Sub LIM
;
Hee Jin CHANG
;
Sang Keun HAHM
;
Ji Hye CHUNG
;
Soo Young KIM
;
Yeol KIM
;
Won Chul LEE
;
Seung Yong JEONG
Author Information
1. Center for Colorectal Cancer, National Cancer Center, Goyang, Korea.
- Publication Type:Editorial
- Keywords:
Early detection of cancer;
Colorectal neoplasms;
Occult blood;
Colonoscopy;
Computed tomographic colonography
- MeSH:
Adult;
Barium;
Colonography, Computed Tomographic;
Colonoscopy;
Colorectal Neoplasms*;
Consensus;
Early Detection of Cancer;
Enema;
Female;
Humans;
Incidence;
Korea;
Male;
Mass Screening*;
Occult Blood
- From:Journal of the Korean Medical Association
2015;58(5):420-432
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Colorectal cancer is the third most common cancer in Korea; it is the second most common cancer in men and the third most common in women. The incidence rate in Korea has continuously increased since 1999 when the National Cancer Registry statistics began. Currently; there are several screening modalities; that have been recommended by expert societies, including fecal occult blood test, colonoscopy, computed tomographic colonography The annual fecal immunochemical test (FIT) has been used in adults aged 50 and older as part of the National Cancer Screening Program in Korea since 2004. Although several study results from regional or national colorectal cancer screening programs in other countries have been reported, the National Cancer Screening Program in Korea has not yet been evaluated with evidence-based methods. Herein report the consensus statements on the National Screening Guideline for colorectal cancer developed by a multi-society expert committee in Korea, as follows: 1) We recommend annual or biennial FIT for screening for colorectal cancer in asymptomatic adults, beginning at 45 years of age and continuing until 80 years (recommendation B). 2) There is no evidence for the risks or benefits of FIT in adults older than 80 years (recommendation I). 3) Selective use of colonoscopy for colorectal cancer screening is recommended, taking into consideration individual preference and the risk of colorectal cancer (recommendation C). 4) There is no evidence for the risks or benefits of double-contrast barium enema for colorectal cancer screening in asymptomatic adults (recommendation I). 5) There is no evidence for the risks or benefits of computed tomographic colonography for colorectal cancer screening in asymptomatic adults (recommendation I).
